Mycronic Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Mycronic ha aumentado sus beneficios a una tasa media anual de 22.3%, mientras que los beneficios de la industria de Electronic han experimentado un crecimiento de 14.4% anual. Los ingresos han ido creciendo a una tasa media de 15.1% al año. La rentabilidad financiera de Mycronic es de 22%, y sus márgenes netos son de 20.1%.
Información clave
22.35%
Tasa de crecimiento de los beneficios
22.36%
Tasa de crecimiento del BPA
| Crecimiento de la industria Electronic | 24.14% |
| Tasa de crecimiento de los ingresos | 15.10% |
| Rentabilidad financiera | 22.03% |
| Margen neto | 20.06% |
| Próxima actualización de resultados | 22 Oct 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Aug 03
MYCR: Higher Guidance And Orders Will Face Lower Margin Pressure
Analysts have lifted their price target for Mycronic from SEK 161 to SEK 211, citing updated assumptions on growth, margins and P/E multiples, along with recent supportive Street research that includes a SEK 385 target. What’s in the News for Mycronic Mycronic received an SLX mask writer order from an existing customer in Asia, valued between US$5 million and US$7 million, with delivery planned for the second quarter of 2027.
Actualización de narrativa • Jul 20
MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential
Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.
Actualización de narrativa • Jul 06
MYCR: Cautious Ratings And New Orders Will Shape Execution Focus
The analyst price target for Mycronic has been revised from SEK 255 to SEK 320, with analysts citing updated assumptions for revenue growth, profit margins and future P/E as they reassess the stock following a series of more cautious rating changes from SEB Equities, Nordea and DNB Carnegie. Analyst Commentary Recent commentary on Mycronic reflects a more cautious tone from several firms, yet the higher SEK 320 price target signals that some bullish analysts still see room for upside if the company delivers on the updated assumptions for revenue, margins and P/E.Actualización de narrativa • Jun 22
MYCR: Sector Downgrades And Execution Risks Will Restrain Future Upside
The latest Narrative Update on Mycronic reflects a reduced analyst price target of SEK260.25, as analysts factor in slightly lower revenue growth and profit margin assumptions, along with a modestly higher future P/E, in the context of several recent downgrades on the stock. Analyst Commentary Recent research on Mycronic points to a more cautious stance among several bearish analysts, who have downgraded the stock while reassessing revenue growth, margins, and valuation multiples.Artículo de análisis • Jun 19
Mycronic (OM:MYCR) Stock Could Be 17.2% Overvalued After New SLX Order
Mycronic (OM:MYCR) stock is back in focus after the company reported a new European customer order for its SLX laser mask writer, valued at US$6 to 8 million with delivery planned in Q3 2026. See our latest analysis for Mycronic. The SLX order lands at a time when Mycronic’s short term share price momentum has been firm, with a 90 day share price return of 44.34%. The 1 year total shareholder return of 70.93% and 3 year total shareholder return of 151.03% point to strong long term...Actualización de narrativa • Jun 07
MYCR: Sector Downgrades And Higher Risk Perceptions Will Pressure Future Upside
Analysts have trimmed their stance on Mycronic, nudging the SEK 260.25 price target lower in line with a slightly higher discount rate and more cautious sector views following several recent rating downgrades. Analyst Commentary Recent research has taken a more cautious tone on Mycronic, with several downgrades pointing to higher required returns and more conservative sector assumptions feeding into valuation work.Actualización de narrativa • May 09
MYCR: Clustered Downgrades And Extended Deliveries Will Pressure Near Term Upside
The updated analyst price target for Mycronic has shifted from SEK 226.50 to SEK 260.25. Analysts cite changes in growth expectations and valuation assumptions, even as several firms have recently turned more cautious on the stock.Artículo de análisis • Apr 29
Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...Actualización de narrativa • Apr 24
MYCR: Extended Delivery Timeline For New Orders Will Restrain Near-Term Upside
Analysts have raised their price target on Mycronic to SEK226.50 from SEK213.67, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Order for a customized SLX mask writer from a new customer, valued between US$27 million and US$30 million, with delivery planned in 2028.Actualización de narrativa • Apr 09
MYCR: Asian Equipment Orders And 2026 Outlook Will Support Steady Dividend Profile
Analysts have slightly adjusted their price target on Mycronic from SEK 215 to about SEK 214. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples, while keeping their overall view broadly consistent.Actualización de narrativa • Mar 26
MYCR: Asian Orders And 2026 Guidance Will Underpin Stable Dividend Outlook
Analysts are maintaining their SEK 215.0 price target for Mycronic, noting only minor adjustments to inputs such as the discount rate, long-term revenue, profit margin and future P/E assumptions that do not materially change their valuation view. What's in the News Mycronic has issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (Corporate Guidance).Actualización de narrativa • Mar 09
MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook
Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.Actualización de narrativa • Feb 22
MYCR: Asian Orders And 2026 Guidance Will Shape Balanced Outlook
Analysts now keep their SEK 215.0 price target for Mycronic broadly unchanged, with slight adjustments in the discount rate, revenue growth expectations, profit margin assumptions, and future P/E multiples shaping the latest narrative update. What's in the News Mycronic issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (company guidance).Artículo de análisis • Feb 08
Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report
Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Actualización de narrativa • Feb 08
MYCR: Asian Orders And Higher Margins Will Support Bullish Outlook
Analysts have trimmed their price target on Mycronic to SEK215 from about SEK218.67, citing updated assumptions that include a slightly higher discount rate, adjusted revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Mycronic announced an annual dividend of SEK 3.25 per share, with an ex dividend date set for May 7, 2026, a record date on May 8, 2026, and a payment date on May 13, 2026 (company announcement).Actualización de narrativa • Jan 24
MYCR: Asian Orders And Cautious Margins Will Support Stable Outlook
Analysts have kept their overall price target for Mycronic unchanged at SEK 218.67, with adjustments in the discount rate, profit margin and future P/E assumptions reflecting a more cautious margin outlook, offset by support from valuation multiples. What's in the News Mycronic received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (company announcement).Artículo de análisis • Jan 23
Mycronic (STO:MYCR) Is Reinvesting To Multiply In Value
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Actualización de narrativa • Jan 08
MYCR: Asian Equipment Orders And Higher Margins Will Support Steady Outlook
Analysts have left their fair value estimate for Mycronic unchanged at SEK 218.67. The latest price target is shaped mainly by slightly revised assumptions on discount rate, revenue growth, profit margin and future P/E, which together reflect a more balanced view of the company’s earnings profile and valuation risk.Artículo de análisis • Dec 31
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Mycronic's estimated fair value is kr215 based on 2 Stage Free Cash Flow to Equity Current share price of...Actualización de narrativa • Dec 13
MYCR: Expanding Asian Orders Will Support Steady Earnings And Balanced Prospects
Analysts have nudged their price target for Mycronic slightly higher to approximately SEK 219 per share, reflecting modestly increased discount rate and future P E assumptions, while maintaining a generally stable view on long term revenue growth and profitability. What's in the News Mycronic secured a new Asian customer for its SLX semiconductor mask writer, an energy efficient system with an order value between USD 5 million and 7 million, with revenue recognized in the current quarter (company announcement).Actualización de narrativa • Nov 27
MYCR: Growing Asian Orders And Margins Will Support Measured Gains Through 2025
Analysts have slightly increased their price target for Mycronic to SEK 218.67 from SEK 217.33. They cite improved revenue growth expectations and a marginally higher projected profit margin.Actualización de narrativa • Nov 07
MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025
Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.Artículo de análisis • Oct 28
Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%
Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...Actualización de narrativa • Oct 24
Upcoming Orders and Expansion Will Drive Global Technology Reach Forward
Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.Actualización de narrativa • Oct 10
Acquisitions And Launches Will Expand Global Technology Reach
Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.Artículo de análisis • Sep 19
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Mycronic fair value estimate is kr235 With kr220 share price...Actualización de narrativa • Aug 27
Acquisitions And Launches Will Expand Global Technology Reach
The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.Artículo de análisis • Aug 23
Does Mycronic (STO:MYCR) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Nueva narrativa • Jun 24
Historically Cheap, but the Margin of Safety Is Still Thin
Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directlyDesglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Mycronic. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 26 | 8,649 | 1,735 | 1,295 | 1,102 |
| 31 Mar 26 | 8,299 | 1,655 | 1,215 | 1,051 |
| 31 Dec 25 | 7,938 | 1,560 | 1,173 | 978 |
| 30 Sep 25 | 7,975 | 1,743 | 1,148 | 917 |
| 30 Jun 25 | 8,046 | 1,974 | 1,070 | 859 |
| 31 Mar 25 | 7,507 | 1,814 | 1,050 | 799 |
| 31 Dec 24 | 7,057 | 1,683 | 989 | 747 |
| 30 Sep 24 | 6,967 | 1,735 | 983 | 704 |
| 30 Jun 24 | 6,461 | 1,490 | 956 | 683 |
| 31 Mar 24 | 6,179 | 1,338 | 971 | 663 |
| 31 Dec 23 | 5,706 | 998 | 996 | 653 |
| 30 Sep 23 | 5,235 | 736 | 981 | 656 |
| 30 Jun 23 | 5,175 | 685 | 1,002 | 651 |
| 31 Mar 23 | 5,203 | 725 | 940 | 653 |
| 31 Dec 22 | 5,119 | 741 | 889 | 638 |
| 30 Sep 22 | 4,916 | 669 | 852 | 605 |
| 30 Jun 22 | 4,688 | 597 | 817 | 587 |
| 31 Mar 22 | 4,479 | 603 | 783 | 567 |
| 31 Dec 21 | 4,635 | 828 | 769 | 548 |
| 30 Sep 21 | 4,334 | 827 | 695 | 538 |
| 30 Jun 21 | 4,415 | 1,012 | 662 | 514 |
| 31 Mar 21 | 4,437 | 1,045 | 654 | 492 |
| 31 Dec 20 | 3,882 | 694 | 671 | 496 |
| 30 Sep 20 | 4,071 | 670 | 743 | 522 |
| 30 Jun 20 | 3,904 | 551 | 796 | 538 |
| 31 Mar 20 | 3,938 | 581 | 806 | 561 |
| 31 Dec 19 | 4,307 | 855 | 778 | 559 |
| 30 Sep 19 | 4,177 | 830 | 758 | 542 |
| 30 Jun 19 | 4,373 | 1,031 | 716 | 524 |
| 31 Mar 19 | 4,136 | 962 | 679 | 501 |
| 31 Dec 18 | 3,781 | 790 | 649 | 476 |
| 30 Sep 18 | 3,655 | 890 | 608 | 440 |
| 30 Jun 18 | 3,049 | 586 | 550 | 410 |
| 31 Mar 18 | 3,072 | 654 | 521 | 369 |
| 31 Dec 17 | 3,000 | 624 | 491 | 348 |
| 30 Sep 17 | 3,090 | 702 | 481 | 354 |
| 30 Jun 17 | 3,096 | 773 | 459 | 342 |
| 31 Mar 17 | 2,653 | 614 | 411 | 352 |
| 31 Dec 16 | 2,319 | 526 | 377 | 348 |
| 30 Sep 16 | 1,925 | 416 | 301 | 317 |
| 30 Jun 16 | 2,033 | 529 | 282 | 311 |
| 31 Mar 16 | 1,855 | 448 | 277 | 282 |
| 31 Dec 15 | 1,815 | 442 | 271 | 267 |
| 30 Sep 15 | 1,850 | 480 | 283 | 250 |
Ingresos de calidad: MYCR tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(20.1%) de MYCR son inferiores a los del año pasado (24.5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lMYCR han crecido significativamente en un 22.3% al año.
Acelerando crecimiento: MYCR ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: MYCR tuvo un crecimiento negativo de los beneficios (-12.1%) durante el año pasado, lo que dificulta la comparación con la media de la industria Electronic (25.1%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera (22%) de MYCR se considera alta.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/08/14 15:47 |
| Precio de las acciones al final del día | 2026/08/14 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Mycronic AB (publ) está cubierta por 9 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Nils Sjogren | ABG Sundal Collier Sponsored |
| Oliver Wong | BofA Global Research |
| Mikael Laséen | Carnegie Investment Bank AB |